Reyon Pharmaceutical Co Ltd Market Cap ($116.84 Million)
Market Cap & Net Worth: Reyon Pharmaceutical Co Ltd (102460)
Reyon Pharmaceutical Co Ltd market cap. Reyon Pharmaceutical Co Ltd (KO:102460) has a market capitalization of $116.84 Million (₩172.41 Billion) as of November 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #18390 globally and #816 in its home market, demonstrating a -3.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Reyon Pharmaceutical Co Ltd's stock price ₩9400.00 by its total outstanding shares 18340991 (18.34 Million). Also see Reyon Pharmaceutical Co Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Reyon Pharmaceutical Co Ltd Market Cap History (2015–2026)
Reyon Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows change from $313.77 Million to $116.84 Million (-6.53% CAGR). Check latest Reyon Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
Reyon Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Reyon Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Reyon Pharmaceutical Co Ltd (102460) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Reyon Pharmaceutical Co Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.04x
Reyon Pharmaceutical Co Ltd's market cap is 0.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $243.90 Million | $121.85 Billion | $10.70 Billion | 0.00x | 0.02x |
| 2017 | $238.33 Million | $126.25 Billion | $12.89 Billion | 0.00x | 0.02x |
| 2018 | $160.15 Million | $122.99 Billion | $1.34 Billion | 0.00x | 0.12x |
| 2019 | $188.55 Million | $131.56 Billion | $5.94 Billion | 0.00x | 0.03x |
| 2020 | $268.26 Million | $130.03 Billion | $3.84 Billion | 0.00x | 0.07x |
| 2021 | $434.69 Million | $142.80 Billion | $5.54 Billion | 0.00x | 0.08x |
| 2022 | $266.55 Million | $154.04 Billion | $7.43 Billion | 0.00x | 0.04x |
| 2023 | $205.58 Million | $151.07 Billion | $3.58 Billion | 0.00x | 0.06x |
| 2024 | $159.59 Million | $148.30 Billion | $4.15 Billion | 0.00x | 0.04x |
Competitor Companies of 102460 by Market Capitalization
Companies near Reyon Pharmaceutical Co Ltd in the global market cap rankings as of November 4, 2026. Also see Reyon Pharmaceutical Co Ltd total assets for a full breakdown of the balance sheet.
Key companies related to Reyon Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Reyon Pharmaceutical Co Ltd (2015–2026)
Market capitalization of Reyon Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Reyon Pharmaceutical Co Ltd's market cap moved from $313.77 Million to $ 116.84 Million, with a yearly change of -6.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩116.84 Million | -12.80% |
| 2025 | ₩133.99 Million | -16.04% |
| 2024 | ₩159.59 Million | -22.37% |
| 2023 | ₩205.58 Million | -22.87% |
| 2022 | ₩266.55 Million | -38.68% |
| 2021 | ₩434.69 Million | +62.04% |
| 2020 | ₩268.26 Million | +42.28% |
| 2019 | ₩188.55 Million | +17.73% |
| 2018 | ₩160.15 Million | -32.80% |
| 2017 | ₩238.33 Million | -2.28% |
| 2016 | ₩243.90 Million | -22.27% |
| 2015 | ₩313.77 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Reyon Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $116.84 Million USD |
| MoneyControl | $116.84 Million USD |
| MarketWatch | $116.84 Million USD |
| marketcap.company | $116.84 Million USD |
| Reuters | $116.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Reyon Pharmaceutical Co Ltd
REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough … Read more